CEACAM5 and neoplasm: Additionally, other pretreatment clinical characteristics, such as gender, age, BMI, tumor volume, tumor diameter, tumor length, T stage, CEA and CA19-9 levels, distance from anal verge, and prescription dose, were balanced between the cohorts, with the exception of N stage (p = 0.025).